A human monoclonal antibody encoded by the V4-34 gene segment recognises melanoma-associated ganglioside via CDR3 and FWR1

Human Antibodies

Volumn 9, Issue 2, 1999, Pages 95-106

  Thomas, Myles D ^a   Clough, Kevin ^a   Melamed, Mark D ^a   Stevenson, Freda K ^b   Chapman, Caroline J ^b   Spellerberg, Myfanwy B ^b,f   Potter, Kathleen N ^b   Newton Bishop, Julia A ^c   Gregson, Norman ^d   Dawson, Karren ^e  

^a UNIVERSITY OF EAST LONDON   (United Kingdom)

^b Tenovus Research Laboratory   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e ROYAL LONDON HOSPITAL   (United Kingdom)

^f UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Autoantibody; Ganglioside; Human monoclonal antibody; Melanoma

Indexed keywords

ARGININE; CANCER ANTIBODY; GANGLIOSIDE ANTIBODY; HUMAN MONOCLONAL ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GERM LINE; HEMAGGLUTINATION; HUMAN; HUMAN CELL; HYBRIDOMA; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 6744248620     PISSN: 10932607     EISSN: None     Source Type: Journal    
DOI: 10.3233/hab-1999-9203     Document Type: Article

References (39)

1. Ruiter DJ, Bhan AK, Harrist TJ, Sober AJ and Mihm MC, Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma, J Immunol 129 (1982), 2808.
2. Ralfiaer E, Hou-Jensen K, Gatter KC, Drzewiecki KT and Mason DY, Immunohistological analysis of the lymphoid infiltrate in cutaneous malignant melanomas, Virchows Arch 410 (1987), 355.
3. Lewis MG, Ikonopisov RL, Nairn RC, Phillips TM, Fairley GH, Bodenham DC and Alexander P, Tumour-specific antibodies in human malignant melanoma and their relationship to extent of the disease, Brit Med J 3 (1969) 547.
4. Bodurtha AJ, Chee DO, Laucius JF, Mastrangelo MJ and Prehn RT, Clinical and immunological significance of human melanoma cytotoxic antibody. Cancer Research 35 (1975), 189.
5. Lewis MG, McCloy E and Blake J, The significance of humoral antibodies in the localization of human malignant melanoma, Brit J Surg 60 (1973), 443.
6. Harris DT and Mastrangelo MJ, Serotherapy of cancer, Seminars in Oncology 16 (1989), 180.
7. Davies AJS, Fallowfield M, McIntosh DP and Forrester JA, On the use of monoclonal antibodies in the therapy of cancer, Lectures Symposia 14th International Congress 5 Budapest (1987), 213.
8. Resifeld RA, Pre-clinical models for immunotherapy of melanoma, Immunity to Cancer II (1989), 183.
9. Welt SW, Carswell EA, Vogel CW, Oettegen HF and Old LJ, Immune and non-immune effector function of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cells. Clin Immunol Immunopath 45 (1987), 214.
10. Irie RF, Sze LL and Saxton RE, Human antibody to OFAI, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines, Proc Natl Acad Sci USA 79 (1982), 5666.
11. Abdel-Wahab Z, Li WP, Darrow D, Nudelman ED, Towell A and Seigler HF, Cell surface reactive human monoclonal antibodies directed to human melanoma-associated gangliosides, Melanoma Research 3 (1993), 415.
12. Katano M, Saxton RE and Irie RF, Human monoclonal antibody to tumor-associated ganglioside GD2, J Clin Lab Immunol 15 (1984), 119
13. Furukawa K, Yamaguchi H, Oettgen HF, Old LJ and Lloyd KO, Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies. Cancer Research 49 (1989), 191.
14. Old LJ, Cancer Immunology: The search for specificity- GHA Clowes Memorial Lecture, Cancer Research 41 (1981), 361.
15. Houghton AN, Taormina MC, Ikeda H, Wantanabe T, Oettgen HF and Old LJ, Serological survey of normal humans for natural antibody to cell surface antigens in melanoma, Proc Natl Acad Sci USA 77 (1980), 4260.
16. Miller G and Lipman M, Release of infectious Epstein-Barr Virus by transformed marmoset leukocytes, Proc Natl Acad Sci USA 70 (1973), 190.
17. b, Transfusion Med 1 (1991), 91.
18. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H and Parks WP, In vitro cultivation of human tumors: Establishment of cell lines derived from a series of solid tumors, J Natl Cancer Inst 51 (1973), 1417.
19. Svennerholm L, Chromatographic separation of human brain gangliosides, Journal Neurochemistry 10 (1963), 613.
20. Bhat NM, Bieber MM, Chapman CJ, Stevenson FK and Teng NNH, Human antilipid A monoclonal antibodies bind to human B cells and the i antigen on cord red blood cells, J Immunol 151 (1993), 5011.
21. Roelcke D, Krefth H and Pfister A, Cold agglutinin Vo. An IgM lambda monoclonal human antibody recognizing a sialic acid determined antigen fully expressed on newborn erythrocytes, Vox Sang 47 (1984), 236
22. Stevenson FK, Wrightham M, Glennie MJ, Jones DB, Cattan AR, Freizi T, Hamblin TJ and Stevenson GT, Antibodies to shared idiotypes as agents for analysis and therapy for human B cell tumors. Blood 68 (1986), 430.
23. H4-21 gene segment, J Exp Med 178 (1993), 1419.
24. H4-21 gene segment, J Immunol 151 (1993), 1051.
25. H4-21 gene segment by anti-DNA antibodies from patients with sytemic lupus erythermatosus, J Autoimmunity 6 (1993), 809.
26. H4-21 gene: a possible link between infection and lupus. Human Antibodies and Hybridomas 6 (1995), 52-56.
27. Leeden RW and Yu RK, Gangliosides structure, isolation and analysis, Methods Enzymology 83 (1982), 143.
28. Ando S and Yu RK, Isolation and characterisation of two isomers of brain tetrasialogangliosides. J Biol Chem 254 (1979), 12224.
29. Furukawa K, Yamaguchi H, Oettgen HF, Old LJ and Lloyd KO. Analysis of the expression of N-glyconeuraminic acid-containing gangliosides in cells and tissues using two human monoclonal antibodies, J Biol Chem 263 (1988), 18507.
30. Vries JE, Keizer GD, Velde AA, Voordouw A, Ruiter D, Rumke P, Spits H and Figdor CG, Characterization of melanoma-associated surface antigens involved in the adhesion and motility of human melanoma cells, Intl J Cancer 38 (1986), 465.
31. Cheresh DA, Pierschbacher MD, Herzig MA and Majoo K, Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins, J Cell Biol 102 (1986), 688.
32. Hamilton WB, Helling F, Lloyd KO and Livingston PO, Ganglioside expression of human malignant melanoma assessed by quantitative immune thin-layer chromatography, Intl J Cancer 53 (1993), 566.
33. Nore GA, Dohi T, Taniguchi M and Hakomon S, Density-dependent recognition of cell surface GM3 by certain antimelanoma antibody, and GM3 lactone as a possible immunogen: requirements for tumor-associated antigen and immunogen, J Immunol 139 (1987), 3171
34. Yamaguchi H, Furukawa K, Fortunato S, Livingston PO, Lloyd KO, Oettgen HF and Old LJ, Cell surface antigens of melanoma recognised by human monoclonal antibodies, Proc Natl Acad Sci 84 (1987), 2416.
35. H restriction among human cold agglutinins, J Immunol 149 (1992), 2337.
36. Pascual V, Victor K, Lelsz D, Spellerberg MB, Hamblin TJ, Thompson KM, Randen I, Narvig J, Capra JD and Stevenson FK, Nucleotide sequence of the V regions of two IgM cold agglutinins, J Immunol 146 (1991). 4385.
37. H4-21 gene, Annals of the New York Academy of Science 76A (1995), 427
38. Li Y, Spellerberg MB, Stevenson FK, Capra JD and Potter KN, The I binding specificity of human VH4-34 (VH4-21) encoded antibodies is determined by both VH framework region 1 and complementarity determining region 3, J Mol Biol 256 (1996), 577.
39. Niemann H, Watanabe K and Hakomori S, Blood group i and I activities of "lacto-N-norhexaosylceramide" and its analogues, Biochem Biophys Res Comm 81 (1978), 1286.